NASDAQ •
Healthcare •
Medical Devices •
Quote as of 09/04/2026
Company Profile
IndustryMedical Devices
SectorHealthcare
ExchangeNASDAQ
Market Capitalization97.06 mln
Float36.30 mln
Earnings Date11/04/2026
Piotroski F-Score
4
/ 9
Borderline
Beneish M-Score
-3.28
Reliable
Relative Strength
28
/ 100
Underperforming
Debt / Equity
1.43
Elevated leverage
Pre-Tax Margin
-54%
Severely loss-making
ROE
-89.70
Deeply negative
Business Description
Pulmonx Corporation develops and sells minimally invasive medical tools designed to help patients living with severe emphysema, a serious lung condition. Its core product, the Zephyr Endobronchial Valve, works alongside diagnostic tools that help doctors evaluate lung function and identify the best areas for treatment. The company also provides a cloud-based imaging service that gives physicians detailed information about lung health to support better treatment planning. Founded in 1995 and based in Redwood City, California, Pulmonx serves patients across the United States and in markets spanning Europe, the Middle East, Africa, and Asia Pacific.
